Adcock Ingram to retrench as SA’s jobs bloodbath hits pharma industry
The pharmaceutical giant recently announced plans to retrench 250 employees at its Clayville plant, north of Johannesburg.
South Africa's ongoing job losses continue to extend to the pharmaceutical sector, with Adcock Ingram, a major player in the industry, facing significant workforce reductions. Within a mere 18 months, the sector has already seen thousands of job cuts, plant closures, and a decline in domestic production capacity.
Recently, Adcock Ingram announced plans to lay off 250 workers at its Clayville plant, north of Johannesburg, due to operational losses and the closure of a division following product recalls. The company claims these decisions were necessary to address underutilized resources and unprofitable product lines. However, the General Industries Workers Union of South Africa (Giwusa) has vehemently rejected this explanation.
After negotiations with the Clayville plant's bargaining council, Adcock Ingram agreed to reduce the number of retrenchments from an initial 250 to between 104 and 84. Union leader Mametlwe Sebei accused the company of prioritizing profits over the well-being of its employees, stating that workers create value while management and shareholders decide how that value is distributed.
Sebei argued that if certain products generate zero or negative margins, the solution should be to adjust the product mix rather than dismiss workers.
Sebei demanded that Adcock Ingram exhaust all other alternatives before resorting to job cuts, insisting that the company must open its books to prove its claims of financial distress.
Written by urgent.news from The Citizen's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
